EUVIMEDEUVIMED entdecken
Crossref

An 8-year single-centre experience of patients with subclinical rheumatic carditis

Ahmet İrdem iD, Selma Oktay Ergin, Alper Kaçar, Fatma Ece Dağdeviren

Cardiology in the Young · 2024

DOI: 10.1017/s1047951124026453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Ahmet İrdem und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatric Cardiology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Myocarditis, Antibiotic Prophylaxis. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Transthoracic echocardiography is the gold standard method for screening and confirmation of acute rheumatic fever and subclinical rheumatic heart disease. Secondary antibiotic prophylaxis that is regularly employed in subclinical rheumatic heart disease may help to reverse mild rheumatic carditis lesions, delay the progression of the disease, reduce morbidity and mortality, and improve patients’ quality of life. Materials and Methods: We retrospectively evaluated the outcomes of 180 patients with subclinical rheumatic heart disease who were followed up for a mean of 4.92 ± 2.0 (3.5–6.5) years.

Results

Between 1 March 2015 and 31 December 2023, 180 patients diagnosed with subclinical rheumatic heart disease with a mean follow-up of 4.92 ± 2.0 (3.5–6.5) years were included in the study. Of the patients, 50.6% were male, 49.4% were female, mean age at diagnosis was 11.74 ± 3.18 (9.68–13.65) years, and mean follow-up period was 4.92 ± 2.0 (3.5–6.5) years. Further, 87.2 % of the patients had mitral valve regurgitation, 38.3% had aortic valve regurgitation, and 27.2% had both valve (aortic and mitral valve) regurgitation. Moreover, Sydenham chorea was also diagnosed in 7.8% the patients. Of the patients, 90% had mild rheumatic heart disease, 7.8% had moderate rheumatic heart disease, and 2.2% had severe rheumatic heart disease. After the diagnosis of rheumatic heart disease, 76.7% patients received regular and 23.3% irregular secondary benzathine penicillin G prophylaxis.

Conclusion

We believe that echocardiography demonstrates its efficacy and safety profile in reducing the risk of rheumatic heart disease in patients diagnosed with subclinical rheumatic carditis and complying with regular secondary antibiotic prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic Heart DiseaseMyocarditisAntibiotic ProphylaxisHumansFemaleMaleRetrospective StudiesChildAdolescentEchocardiographyFollow-Up StudiesMitral Valve InsufficiencyAnti-Bacterial AgentsQuality of LifeAortic Valve Insufficiency

Stichwörter der Autor:innen

childrensecondary prophylaxissubclinic rheumatic carditis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pediatric Cardiology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Department of Pediatric, İstanbul Prof. Dr Cemil Taşcıoğlu City Hospital, İstanbul, Turkey.

ORCID-Profile: Ahmet İrdem

Zitieren

APA

İrdem, A., Ergin, S. O., Kaçar, A., & Dağdeviren, F. E. (2024). An 8-year single-centre experience of patients with subclinical rheumatic carditis. Cardiology in the Young. https://doi.org/10.1017/s1047951124026453

Vancouver

İrdem A, Ergin SO, Kaçar A, Dağdeviren FE. An 8-year single-centre experience of patients with subclinical rheumatic carditis. Cardiology in the Young. 2024. doi:10.1017/s1047951124026453

BibTeX
@article{rdem2024,
  author = {İrdem, Ahmet and Ergin, Selma Oktay and Kaçar, Alper and Dağdeviren, Fatma Ece},
  title = {An 8-year single-centre experience of patients with subclinical rheumatic carditis},
  journal = {Cardiology in the Young},
  year = {2024},
  doi = {10.1017/s1047951124026453}
}
Kostenlos starten →